J Y Fagon
Overview
Explore the profile of J Y Fagon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
1579
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Belghiti J, Oget-Gendre C, Berthon A, Fagon J
J Visc Surg
. 2021 Mar;
158(3S):S6-S11.
PMID: 33716003
Introduction: The Delegation for Innovation in Health Care (DIES) was created by the Ministry of Solidarity and Health to centralize and support innovative health care projects. Following its dissolution, only...
2.
Llitjos J, Daviaud F, Grimaldi D, Legriel S, Georges J, Guerot E, et al.
Ann Intensive Care
. 2016 Jan;
6(1):8.
PMID: 26782681
Background: Clinical features and outcomes of patients with spontaneous ilio-psoas hematoma (IPH) in intensive care units (ICUs) are poorly documented. The objectives of this study were to determine epidemiological, clinical,...
3.
Grohs P, Podglajen I, Guerot E, Bellenfant F, Caumont-Prim A, Kac G, et al.
Clin Microbiol Infect
. 2014 May;
20(11):O879-86.
PMID: 24807791
There is no consensus on optimal screening procedures for multidrug-resistant Enterobacteriaceae (MDRE) in intensive care units (ICUs). Therefore, we assessed five strategies for the detection of extended-spectrum beta-lactamase (ESBL) and...
4.
Tadie J, Heming N, Serve E, Weiss N, Day N, Imbert A, et al.
Resuscitation
. 2011 Sep;
83(3):399-401.
PMID: 21907690
Purpose: Pneumonia is the most common infectious complication of drowning. Pneumonia is potentially life threatening and should be treated by effective antibiotic therapy. However the risk factors, microbiological causes, diagnostic...
5.
Fagon J, Chastre J
Eur Respir J Suppl
. 2003 Aug;
42:77s-83s.
PMID: 12946005
Ventilator-associated pneumonia (VAP) is a common complication of the acute respiratory distress syndrome (ARDS) or acute lung injury (ALI), often leading to the development of sepsis, multiple organ failure, and...
6.
7.
Fagon J
Rev Pneumol Clin
. 2001 May;
57(2):132-8.
PMID: 11353919
Nosocomial pneumonia occurs in 0.5 to 1.5% of all hospitalized patients and in 10 to 30% of those under artificial ventilation. The main causal agents are Staphylococcus aureus and resistant...
8.
Fagon J
Presse Med
. 2001 Jan;
29(37):2044-5.
PMID: 11155731
AN UNRESOLVED ISSUE: Inappropriate duration of antibiotic treatment is one of the factors explaining the high mortality of nosocomial pneumonia. There are however few data on the ideal duration of...
9.
Fagon J, Chastre J, Wolff M, Gervais C, Stephan F, Similowski T, et al.
Ann Intern Med
. 2000 Apr;
132(8):621-30.
PMID: 10766680
Background: Optimal management of patients who are clinically suspected of having ventilator-associated pneumonia remains open to debate. Objective: To evaluate the effect on clinical outcome and antibiotic use of two...
10.
Roupie E, Lepage E, Wysocki M, Fagon J, Chastre J, Dreyfuss D, et al.
Intensive Care Med
. 1999 Sep;
25(9):920-9.
PMID: 10501746
Objective: To evaluate the prevalence and outcome of the acute respiratory distress syndrome (ARDS) among patients requiring mechanical ventilation. Design: A prospective, multi-institutional, initial cohort study including 28-day follow-up. Settings:...